Drugs, Docs and Diggs: clash? You bet.
Physicians who have more frequent contact with the pharmaceutical industry are less likely to prescribe generic drugs and more likely to prescribe new drugs.3
The pharmaceutical industry may be influencing clinical practice guidelines and are beginning to fund postgraduate education. Major medical journals require authors to reveal any potential conflicts of interest with pharmaceutical companies; however, there is no similar requirement for clinical practice guideline panel members. whether we continue to slip backward, every facet of our profession is in danger of being dominated by pharmaceutical industry agendas.
Melissa M. Another concerning trend is that residency and fellowship programs are using pharmaceutical monies to fund residency activities.4,5
Where are the major medical associations on these issues?
Letters to the Editor of American Family Physician
Medicine and the Pharmaceutical Industry:
A shout to Action
TO THE EDITOR:
At our practice, we continue to regularly receive a barrage of invitations to free dinners, offers to attend professional athletic venues, and all-expenses-paid consultant meetings at five-star hotels. In a cross-sectional survey of 192 authors of 44 clinical practice guidelines published amidst 1991 and 1999, 87 percent had some tie with the pharmaceutical industry, and 58 percent had received financial support to perform the research. Seek the advice of a physician. These events are sponsored by pharmaceutical companies under the umbrella of medical education and research. Systematic reviews have confirmed that prescribing patterns of physicians differ depending on the frequency of contacts with pharmaceutical representatives. Our leaders need to address the industry influence on publication bias, clinical practice guidelines, CME, and medical education.
Many medical doctors are fed up with drug reps as well - and these two docs let AFP know that loud and clear. General Accountability Office, drug companies
spent $16 billion on direct marketing to physicians in the United States in 2001, more than $19,000 per physician. The data here is published with full copyright by HealthE Goods and Benjamin Lynch.
According to the U.S. Why is that still occurring? The letter to the editor that week is particularly cool and needs to be shared to all. In the late 1980s and early 1990s, the major medical organizations and medical journals established guidelines to address the relationship amidst the pharmaceutical industry and medicine. 
I read the weekly newsletter from American Family Physician. Major journals are dominated by pharmaceutical advertisements, and continuing medical education (CME) is increasingly being underwritten by pharmaceutical companies. Studies and literature reviews show that gifts to physicians from the pharmaceutical industry influence prescribing patterns of residents and physicians, and the formulary requests of physicians.1
Despite that, the amount of money pharmaceutical companies spend on direct marketing to physicians continues to rise at a rapid pace. At major medical meetings, physicians are enveloped in the embrace of the pharmaceutical industry from registration to the exhibition hall to “breakfast and dinner lectures.” It is duration for our major associations to step forward and address the effect the pharmaceutical industry has on rising drug costs and rational prescribing patterns. Stiles, MD
bruce barrett, md, phd
University of Wisconsin
University of Wisconsin
Department of Family Medicine
777 South Mills
Madison, WI 53715
Madison, WI 53715
Disclaimer: that info is not approved by the FDA or to be used as treatment advice. Promotions to physicians accounted for more than 80 percent of all marketing spending by drug companies in 2001. Direct-to-consumer spending by pharmaceutical companies was $2.7 billion in 2001, up 145 percent since 1997.2
The amount of money spent on promotional activities affects prescribing habits and the cost of medications.
Original post by Benjamin
No comments yet. Be the first.
Leave a reply
